Trial of Therapeutic Hypothermia in Patients With ARDS (CHILL)
view all Clinical Trials
Overview
The CHILL trial is designed to evaluate whether TH combined with NMBA is beneficial in patients with ARDS. Phase IIb randomized clinical trial.
Contact
For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.